| Non-Small Cell Lung Cancer |
1 |
1 |
| Lung Cancer |
0 |
0.95 |
| Biologic Therapy |
0 |
0.98 |
| Neoadjuvant Therapy |
0 |
0.99 |
| Chemotherapy |
0 |
0.55 |
| Immunotherapy |
0 |
0.97 |
| Toxicology |
0 |
0.2 |
| Polymerase Chain Reaction |
0 |
0.17 |
| Postoperative |
0 |
0.17 |
| Surgery |
0 |
0.17 |
| Cancer |
0 |
0.13 |
| Perioperative Care |
0 |
0.13 |
| Targeted Cancer Therapy |
0 |
0.13 |
| Anaplastic Lymphoma Kinase |
0 |
0.08 |
| KRAS |
0 |
0.08 |
| Resection |
0 |
0.08 |
| Tobacco Cessation |
0 |
0.07 |
| Tobacco Use |
0 |
0.07 |
| Adjuvant Therapy |
0 |
0.96 |